Mice Model Market (Product Type: Transgenic Mice Model, Hybrid/Congenic Mice Model, Knockout Mice Model, Carcinogen-induced & Spontaneous Mice Model, Outbred Mice Model, Inbred Mice Model, Transplantation Mice Model, and Conditioned/Surgically Modified Mice Model; Specialty: Immunology, Central Nervous System [CNS], Oncology, Cardiovascular, Diabetes, and Metabolism & Regulation; and Service: Breeding & Rederivation Services, Cryopreservation & Cryorecovery Services, Quarantine Services, Genetic Testing Services, Model In-licensing Services, In Vivo & In Vitro Pharmacology Services, Genetically Engineered Model Services, and Other Services [Surgical and Line Rescue]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2030

The global Mice Model market gathered revenue around USD 12.7 billion in 2021 and market is set to grow USD 30.4 billion by the end of 2030 and is estimated to expand at a modest CAGR of 9.2% during the prediction period 2022 to 2030.

Growth Factors:

Mice have been one of the most important research tools for basic and applied research in biomedical sciences and continues to grow at a rapid rate. Besides providing precise correlation with human condition, the major advantage of mice models is the prospect of exploring precise gene-specific functions and various molecular events in a living organism. Combining mice models with advanced imaging technologies provide unique opportunities to understand the etiology and pathophysiology of human diseases. Furthermore, mice have been widely used in biomedical research to discover human diseases and to evaluate new drug candidates. Mouse research has led to major advances in treating a number of diseases and conditions. For instance, experiments on mice models resulted in efficacious treatments for acute promyelocytic leukemia, or APL, which was largely terminal.

North America was the largest market for mice model in 2021. The region dominated the global market due to substantial investments in the field, impressive economic growth, and increased research & development expenditure. Countries in Asia Pacific offer immense opportunities for research animal manufacturers, and the region is currently adopting advanced animal models for the research and drug discovery process. The mice model market in Asia Pacific is primarily dominated by multinational companies, particularly in transgenic and knockout mice models. These companies account for over 50% share of the market in countries such as Singapore, Malaysia, India, and China.

Report Scope of the Mice Model Market

Personalized In Vivo Analysis Mice Models to Increase Demand For Mice Models in Personalized Medicine to Drive Market

Advances in gene technology, fueled by the need of fast, accurate treatment in the ever-evolving medical industry, are accelerating the growth of the global mice model market. Identification of genomic differences to predict drug resistance or drug response by the patients can offer scope to design a customized therapy tailored to the specific characteristics of a particular cancer. The Mouse Avatar and Co-clinical Trial concepts have the potential to revolutionize the drug development and health care process.

Inbred Mice Model Segment to Dominate Mice Model Market

In terms of model type, the global mice model market has been classified into transgenic mice model, hybrid/congenic mice model, knockout mice model, carcinogen-induced & spontaneous mice model, outbred mice model, inbred mice model, transplantation mice model, and conditioned/surgically modified mice model. The inbred mice model segment accounted for leading share of the global mice model market in 2021 due to advantages such as cost effectiveness and data reproducibility.

The hybrid/congenic segment is expected to expand at the fastest CAGR during the forecast period from 2017 to 2030 due to increase in applications in immunology, oncology, and cardiovascular studies.

Metabolism & Regulation to be Highly Lucrative Segment

Based on specialty, the global mice model market has been categorized into immunology, central nervous system, oncology, cardiovascular, diabetes, and metabolism & regulation. Metabolism & regulation was the largest segment of the global market in terms of revenue in 2021 due to increase in usage of mice model to study the diseases. The diabetes segment is likely to expand at the fastest CAGR during the forecast period due to rise in prevalence of the disease across the globe, particularly in developed countries.

Genetic Testing Segment to Dominate Market

In terms of service, the global mice model market has been divided into breeding & rederivation services, cryopreservation & cryorecovery services, quarantine services, genetic testing services, model in-licensing, in vivo & in vitro pharmacology services, genetically engineered model services, and other services. The genetic testing services segment dominated the global mice model market in 2020. Rise in importance of customized models in applied research as well as in the development and production of vital biomolecules is a major factor fueling the growth of the segment.

North America to Dominate Global Market

In terms of region, the global mice model market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global mice model market in 2021, followed by Europe. North America's dominance can be attributed to the presence of a large number of research institutions and biopharmaceutical companies that have been instrumental in driving the mice model market in the region.

Europe exhibits immense growth potential, as Western Europe has witnessed relatively higher adoption rate of rodents in the past few years.

Some of the prominent players in the Mice Model Market include:

• Charles River Laboratories
• Crescendo Biologics Limited
• Deltagen, Inc.
• GenOway S.A.
• Harlan Laboratories, Inc.
• ImmunoGenes AG
• Taconic Biosciences, Inc.
• Lexicon Pharmaceuticals
• SAGE Labs
• The Jackson Laboratory
• Taconic Biosciences, Inc.
• TransGenic, Inc., among others

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

Global Mice Model Market: Segmentation

Mice Model Market, by Type

• Transgenic Mice Model
• Hybrid / Congenic Mice Model
• Knockout Mice Model
• Carcinogen/induced & Spontaneous Mice Model
• Outbred Mice Model
• Inbred Mice Model
• Transplantation Mice Model
• Conditioned / Surgically Modified Mice Model

Mice Model Market, by Specialty

• Immunology
• Central Nervous System
• Oncology
• Cardiovascular
• Diabetes
• Metabolism & Regulation

Mice Model Market, by Service

• Breeding & Rederivation Services
• Cryopreservation & Cryorecovery Services
• Quarantine Services
• Genetic Testing Services
• Model In-licensing Services
• In Vivo & In Vitro Pharmacology Services
• Genetically Engineered Model Services
• Other Services (Surgical and Line Rescue)

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Points Covered in Mice Model Market Study:

• Growth of Mice Model in 2022
• Market Estimates and Forecasts (2017-2030)
•  Brand Share and Market Share Analysis
•  Key Drivers and Restraints Shaping Market Growth
•  Segment-wise, Country-wise, and Region-wise Analysis
•  Competition Mapping and Benchmarking
•  Recommendation on Key Winning Strategies
•  COVID-19 Impact on Demand for Mice Model and How to Navigate
•  Key Product Innovations and Regulatory Climate
•  Mice Model Consumption Analysis
•  Mice Model Production Analysis
•  Mice Model and Management